Medical Pharmaceuticals Headlines from PR Newswire

< Go Back

Global Biometrics Market in the Healthcare Industry 2014-2018
Gateway Analytical to Present with the FDA on Chemically Specific Analysis of Orally Inhaled Drug Products at the Respiratory Drug Delivery Conference in Puerto Rico
Advance LA 2014 Resilience Conference to Feature Leading Experts in Autism, Learning Disabilities And ADHD
Marken Ready for Orphan Drug Distribution
Actavis Announces Celebrex® Patent Challenge Settlement
ALPHAEON™ Expands Partnership with TEOXANE Laboratories
Dr. David Stockwell Joins Pascal Metrics as Vice President of Clinical Services
MacuLogix® Appoints Clinical Advisory Board Member
Cannabis Capital Corp. (CBCA) Acquires WebCongress, Inc. for Cash, Shares, and Management Fees Valued over USD 25 Million
Infertility Leaders at Reproductive Medicine Associates of New Jersey Proudly Announce Sponsorship of the March of Dimes
A Single-Treatment Solution: The Laser Treatment That Revolutionized Skin Care
Global Medical Publishing Market 2014-2018
Olympus Reduces Risk of Cross-Contamination and Costly Repairs with ALT-Pro Automatic Leak Tester for Endoscope Reprocessing
Bayer Receives CancerCare® Honor at 70th Anniversary Celebration Gala
Only One Year After Launching, Award-Winning Rising Tide Car Wash Has Made Unprecedented Strides in Empowering Young Adults with Autism
Omnicell to Release First Quarter 2014 Earnings Results on May 1
BD Launches New Point-of-Care System for HIV/AIDS Patients
Skyline Medical Begins Multi-Site Installations of STREAMWAY® System for Minnesota Health Group
UC Charting Solutions Signs Partnership Agreement With Halfpenny Technologies
US Drug Watchdog Escalates Initiative to Help Victims of Premature All-Metal Hip Implant Failure
Vape Holdings Closes In Excess of $100k in HIVE Sales in April, Has $250k in Orders Awaiting Product Arrival
Avellino Lab USA Launches New DNA Test for LASIK Safety
Syneron Medical to Report First Quarter 2014 Financial Results on May 14, 2014
Epizyme Announces Notice of Allowance for U.S. Patent Application Covering Methods of Treatment for Cancers with EZH2 Inhibitors
CVS/pharmacy® To Support Safer Communities through Donation of Drug Collection Units to Police Departments Nationwide
Michael S. Gordon, MD named medical director for Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q1 2014 Results With Sales Of $689 Million And Adjusted Diluted EPS Of $1.06. Reaffirms Full-Year 2014 Adjusted Diluted EPS Guidance Of $4.30 To $4.40.
New Prostate Cancer Blood Test Now Available in the US
Juno Completes $176M Series A Round
New clinical study demonstrates TRUCLEAR◊ 5.0 System as a favorable treatment for a common gynecological condition, right in the doctor's office
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie
Cardica MicroCutter® XCHANGE 30 Featured At Society Of American Gastrointestinal And Endoscopic Surgeons Meeting
TPI Presented at Guosen Securities Investment Conference at Shenzhen, China
Tampa General Hospital launches advanced intraoperative MRI use with first cases English English Spanish
Oncothyreon Announces First Quarter 2014 Financial Results Conference Call English Portuguese
Global Condom Market 2014-2018
Endo Acquires Rights to Sumavel® DosePro® Portuguese
Global RNAi Drug Delivery Market 2014-2018
A Common Sense Approach to Appropriate Drug Use
Questcor to Report First Quarter Financial Results on April 28, 2014
Zimmer Holdings, Inc. Reports First Quarter 2014 Financial Results
Global Chemical Vapor Deposition Market 2014-2018
Global Central Venous Access Devices Market 2014-2018
Lilly Reports First-Quarter 2014 Results
Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project
Celsion Corporation Announces Updated Overall Survival Results from the HEAT Study of ThermoDox® in Primary Liver Cancer Presented at ECIO 2014
OrbusNeich Names B. Wayne Johnson President and Chief Operating Officer and Expands Board of Directors
Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014
Microscopy Markets

< Prev Next >
PR Newswire - United Business Media